About the study
This clinical study is assisting in the development of a new medication to provide a better treatment option for people born with achondroplasia – the most common type of disproportionate dwarfism. Skeletal Dysplasia (such as achondroplasia) is a group of conditions where bones don’t fully develop resulting in short stature and unusual limb proportions. There are currently only limited treatment options available.
Volunteers will be reimbursed $2,850 for their time to assist in this study.
The current study schedule is available here (pdf).
How do I get involved?
If you are interested in participating or would like more information, please register below.